The Times of India News

Ozempic is finally in India, but what should you really know before getting swept up in the hype?

Ozempic, a GLP-1 receptor agonist, has officially launched in India, offering a new treatment option for type 2 diabetes. While known for its weight loss benefits, its approved use in India is solely for diabetes management, with weight loss being a secondary effect. Doctors emphasize consulting them for appropriate use, as it's not a casual weight-loss solution.